Capricor Therapeutics
CAPR
#4976
Rank
NZ$2.89 B
Marketcap
NZ$50.29
Share price
-3.51%
Change (1 day)
149.55%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$1.17 M-99.26%
2025NZ$0.15 B154.62%
2024NZ$61.89 M1584.06%
2023NZ$3.67 M24.67%
2022NZ$2.94 M-49.93%
2021NZ$5.88 M-88.57%
2020NZ$51.49 M573.14%
2019NZ$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
NZ$29.18 MNZ$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$4.98 MNZ$27.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$14.09 MNZ$40.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.83 MNZ$11.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$0.8 MNZ$1.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/ANZ$0.07 M๐Ÿ‡บ๐Ÿ‡ธ USA